GCM
Gables Capital Management’s Lexaria Bioscience LEXX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11 | Hold |
13
| – | – | ﹤0.01% | 442 |
|
|
2025
Q1 | $22 | Hold |
13
| – | – | ﹤0.01% | 442 |
|
|
2024
Q4 | $27 | Hold |
13
| – | – | ﹤0.01% | 443 |
|
|
2024
Q3 | $40 | Hold |
13
| – | – | ﹤0.01% | 443 |
|
|
2024
Q2 | $36 | Hold |
13
| – | – | ﹤0.01% | 394 |
|
|
2024
Q1 | $47 | Hold |
13
| – | – | ﹤0.01% | 388 |
|
|
2023
Q4 | $16 | Hold |
13
| – | – | ﹤0.01% | 377 |
|
|
2023
Q3 | $13 | Buy |
+13
| New | +$13 | ﹤0.01% | 363 |
|
|
2023
Q2 | – | Sell |
-13
| Closed | -$35 | – | 379 |
|
|
2023
Q1 | $35 | Hold |
13
| – | – | ﹤0.01% | 374 |
|
|
2022
Q4 | $32 | Hold |
13
| – | – | ﹤0.01% | 358 |
|
|
2022
Q3 | $0 | Hold |
13
| – | – | ﹤0.01% | 346 |
|
|
2022
Q2 | $0 | Hold |
13
| – | – | ﹤0.01% | 354 |
|
|
2022
Q1 | $0 | Hold |
13
| – | – | ﹤0.01% | 349 |
|
|
2021
Q4 | $0 | Hold |
13
| – | – | ﹤0.01% | 354 |
|
|
2021
Q3 | $0 | Buy |
+13
| New | – | ﹤0.01% | 358 |
|